Few studies have investigated the epigenetic regulation of the Ppar-a gene promoter in obesity, cardiac and intestine pathologies, and liver disease, where the DNA methylation of PPAR-α has been suggested as a therapeutic approach for non-alcoholic fatty liver disease [32]. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.